Clinical trial Recruiting at 1 site Observational Ages 18 and up

Testing the Glasgow-Blatchford bleeding score in Tunisian adults with upper gastrointestinal bleeding

Official title: External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population

Run by Hôpital Universitaire Sahloul · NCT07089277 · Data updated 2026-11-12

This project will see if the Glasgow‑Blatchford Score can predict 30‑day complications in adults in Tunisia who come to the emergency department with non‑traumatic upper gastrointestinal bleeding.

More Upper Gastrointestinal Bleeding (UGIB) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorHôpital Universitaire Sahloul
Academic / other
Locations1 site (Sousse)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 30, 2025
Study endsDecember 30, 2025
Registry record updatedJuly 28, 2025
Trial IDNCT07089277 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) presenting to participating Tunisian emergency departments with non‑traumatic upper gastrointestinal bleeding who consent and have complete follow‑up data.

Probably not a fit

Patients under 18, those with traumatic or non‑upper GI bleeding (for example isolated hemorrhoidal bleeding), or those who do not consent or are lost to follow‑up are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational study will enroll adults (≥18 years) presenting with non‑traumatic upper gastrointestinal bleeding to participating emergency departments, with clinical and epidemiological data collected using a standardized form. Investigators will calculate each patient's Glasgow‑Blatchford Score at presentation and follow patients for 30 days to record outcomes including rebleeding, need for hemostatic intervention, complications, and mortality. Statistical analysis will measure the score's predictive performance using sensitivity, specificity, and predictive values for 30‑day outcomes. The goal is to determine whether the GBS can reliably stratify risk in the Tunisian setting where routine hospitalization of all patients is common.

Why it matters

Potential benefit: If successful, the GBS could help clinicians identify low‑risk patients who may avoid unnecessary hospitalization and allow resources to be focused on higher‑risk individuals.

How similar studies have gone: The Glasgow‑Blatchford Score has demonstrated predictive utility in multiple international cohorts, although validation data specific to Tunisia are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (≥18 years) presenting with non-traumatic upper gastrointestinal bleeding

Exclusion Criteria:

* patients under 18 years of age.

Diagnosis of external hemorrhoids with mucosal lesions.

Patients who do not consent, are lost to follow-up, or have incomplete data.

Where it's running

  • Sahloul University Hospital
    Sousse, Tunisia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.